Literature DB >> 3198495

Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.

T Yoshioka1, K Kiyoshima, M Maeda, M Sakamoto, T Ishikura, Y Fukagawa, T Sawa, M Hamada, H Naganawa, T Takeuchi.   

Abstract

Eleven 4''-O-acyltylosin derivatives were synthesized and subjected to a two-step screening system consisting of antimicrobial activity and esterase stability assays. The new derivatives were all active against macrolide-resistant Staphylococci and mycoplasmas, but only 4''-O-(4-methoxy)phenylacetyltylosin and 4''-O-(4-acetyl)phenylacetyltylosin showed better resistance to mouse liver esterase than 4''-O-phenylacetyltylosin (reference compound C).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198495     DOI: 10.7164/antibiotics.41.1617

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  In vitro activity of YM133, a new semisynthesized macrolide.

Authors:  T Terasawa; M Watanabe; T Okubo; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.

Authors:  Thomas W von Geldern; Howard E Morton; Rick F Clark; Brian S Brown; Kelly L Johnston; Louise Ford; Sabine Specht; Robert A Carr; Deanne F Stolarik; Junli Ma; Matthew J Rieser; Dominique Struever; Stefan J Frohberger; Marianne Koschel; Alexandra Ehrens; Joseph D Turner; Marc P Hübner; Achim Hoerauf; Mark J Taylor; Stephen A Ward; Kennan Marsh; Dale J Kempf
Journal:  PLoS Negl Trop Dis       Date:  2019-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.